Emergen Research Logo

The atherosclerosis drugs market is projected to witness substantial growth, with an expected value of USD 60.97 billion by 2030

VANCOUVER, BRITISH COLUMBIA, CANADA, June 13, 2023/EINPresswire.com/ -- The Latest research study released by Emergen Research on "Atherosclerosis Drugs Market" with 150+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that leads the market growth.

The global atherosclerosis drugs market size reached USD 48.40 Billion in 2021 and is expected to register a revenue CAGR of 2.5% during the forecast period, according to latest analysis by Emergen Research. An increase in the prevalence of atherosclerosis & cardiovascular diseases is the main factor driving the revenue growth of the atherosclerosis drugs market. Globally, the number of cardiovascular disease-related deaths and disabilities has been continuously increasing over the past 30 years. The illness, which includes heart disease and stroke, was to blame for a startling one-third of all fatalities globally in 2019. In the United States alone, heart disease is the leading cause of death for both sexes and members of the majority of racial and ethnic groups. Cardiovascular disease claims one life in the United States every 34 seconds. In the United States, heart disease claimed the lives of almost 697,000 individuals in 2020, accounting for 1 in 5 fatalities. Between 2017 and 2018, heart disease cost the USD 229 billion annually. This covers the price of prescription drugs, healthcare services, and lost income from deaths.

To Get Free Sample PDF Copy of This Report

https://www.emergenresearch.com/request-sample/1300

Atherosclerosis Drugs Market, By Drug Class (Statins, Fibrates, Vitamins, Others), By Medication (Cholesterol Lowering Medication, Beta Blockers, Calcium Channel Blockers, Diuretics, Others), By Distribution Channel, By Region Forecast to 2030. An increase in the prevalence of atherosclerosis & cardiovascular diseases is the main factor driving the revenue growth of the atherosclerosis drugs market. Globally, the number of cardiovascular disease-related deaths and disabilities has been continuously increasing over the past 30 years.

Key Players Included in this report are:

Sanofi, Hoffmann La-Roche Ltd, Bayer AG, Merck & Co., Inc., Pfizer Inc., Novartis AG, GSK plc, Janssen Global Services, LLC, Amgen Inc., Mylan N.V.

What can be explored with the Atherosclerosis Drugs Market Study?

Gain Market Understanding

Identify Growth Opportunities

Analyze and Measure the Global Atherosclerosis Drugs Market by Identifying Investment across various Industry Verticals

Understand the Trends that will drive Future Changes in Atherosclerosis Drugs Market

Understand the Competitive Scenarios

Track Right Markets

Identify the Right Verticals

Quick Buy Atherosclerosis Drugs Market

https://www.emergenresearch.com/purchase-enquiry/1300

In the atherosclerosis drugs market, a notable trend is the utilization of natural products and a cell model approach to develop antiatherosclerotic drugs. Subclinical atherosclerosis poses a significant medical and societal challenge, lacking a widely accepted treatment. Synthetic medicines for early-stage arteriosclerosis prevention fall short due to severe side effects and high costs. Consequently, there is a preference for effective antiatherosclerotic medications derived from natural products.

Research Methodology

Emergen Research follows a cohesive methodology to reduce the residual errors to a minimum level by refining the scope, validating through primary insights, and nurturing the in-house database on a regular basis. A dynamic model is formulated to capture the regular fluctuations in the market and thereby, being updated with any shifts in the market dynamics.

SECONDARY RESEARCH MODEL

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources, annual report of companies, SEC filings, government press release, pricing databases and many more.

PRIMARY RESEARCH MODEL

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts. Discussions with the subject matter experts were conducted to obtain quantitative and qualitative information and validate our market research findings.

Market Segmentation Analysis

Players can concentrate on high-growth regions and, if necessary, modify their business plan according to the research report. The Atherosclerosis Drugs Market is divided into a variety of categories, uses, and geographical areas. Players gain from the report's regional segmentation research since it offers pertinent data and insights into important geographic marketplaces.

Drug Class Outlook (Revenue, USD Billion; 2019-2030)
Statins
Fibrates
Vitamins
Others
Medication Outlook (Revenue, USD Billion; 2019-2030)
Cholesterol Lowering Medication
Beta Blockers
Calcium Channel Blockers
Diuretics
Others
COVID-19 Impact Analysis

The post-COVID-19 phase has undergone substantial change, and Atherosclerosis Drugs Market research highlights the opportunities and difficulties that still exist. This study report thoroughly examines the effects of the COVID-19 pandemic on the global economy and post-pandemic market behaviour.

Ask for Customization

https://www.emergenresearch.com/request-history/1300

Some Key Highlights From the Report

Statins segment accounted for the largest revenue share in 2021. Lipid-lowering therapy has been the cornerstone of cardiovascular risk reduction and prevention. Statin drugs have been shown to considerably reduce cardiovascular disease morbidity and mortality as well as blood cholesterol levels.
Cholesterol lowering medication segment accounted for the largest revenue share in 2021. The growing use of these medications is anticipated to drive the segment's market revenue growth. The development of fatty deposits in the arteries can be slowed down, stopped, or even reversed by aggressively reducing Low-Density Lipoprotein (LDL), also referred to as the "bad" cholesterol. Statins are frequently employed to lower cholesterol, keep arteries in good condition, and prevent atherosclerosis.
The online pharmacy segment accounted for the largest revenue share in 2021. This market segment is growing owing to an increase in the number of online services available as well as a sharp rise in internet users. Customers use e-commerce websites to avoid the trouble of going shopping in person, where they can choose from a wide variety of items and take advantage of beneficial bargains and discounts.
Regional Outlook

We carefully examined each division, regional classification, national study, and subject-specific data set during the market research. This Atherosclerosis Drugs Market research report's goal is to look at growth patterns, promising futures, important obstacles, and expected results. Information on significant market participants, strategic alliances, plans, new product launches, and joint ventures are all included in the research.

Key Reasons to Purchase Atherosclerosis Drugs Market Report

The reader will be in a position to comprehend and react to marketing strategies like using strengths and conducting a SWOT analysis.

The research looks into the dynamics of the target market and how the conflict between Russia and Ukraine has affected it.

Look Over transcripts provided by Emergen Research

Molecular Diagnostics Market: https://www.emergenresearch.com/industry-report/molecular-diagnostics-market

Biomaterials Market: https://www.emergenresearch.com/industry-report/biomaterials-market

Automotive Refinish Coatings Market: https://www.emergenresearch.com/industry-report/automotive-refinish-coatings-market

Biophotonics Market: https://www.emergenresearch.com/industry-report/biophotonics-market

Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.